Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ENOSF1 protein | affects expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of ENOSF1 mRNA | increases expression | 12875902
|
D005472 |
Fluorouracil |
ENOSF1 protein affects the susceptibility to Fluorouracil | affects response to substance | 15548681
|
D005472 |
Fluorouracil |
ENOSF1 protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 18357371
|
C054474 |
manumycin |
manumycin affects the localization of ENOSF1 protein | affects localization | 18357371
|
C054474 |
manumycin |
manumycin results in decreased expression of ENOSF1 protein | decreases expression | 18357371
|
D008727 |
Methotrexate |
ENOSF1 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of ENOSF1 mRNA | increases expression | 12875902
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.71 | 12039119 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.48 | 17638652 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.87 | 15955085 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
4.02 | 15504547 17963324 16511603 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.25 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
5.07 | 17286800 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
5.07 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.42 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.78 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.93 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.07 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.07 | 18357371 15136595 18608205 19217205 16557594 16110121 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.07 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.07 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.05 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.19 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.82 | 17121937 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.68 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.87 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
4.87 | 17088986 16332177 17971768 17045692 16799960 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.87 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.14 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
8.05 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
8.05 | 16757204 17066447 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
8.05 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.26 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.05 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.68 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.78 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.12 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.27 | 16340194 17725105 17018589 16510598 17172411 15001691 17169374 18772588 17016597 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 16391804 20501625 18448328 17454858 17094418 15148649 17594712 16282729 17016601 16524972 17255274 18383874 18949393 18802399 18288408 16303861 16331619 17695437 17401013 18509181 14970324 15289873 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.03 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.03 | 10589399 9664655 17551590 9125849 9142499 8800419 16925845 14991402 9211117 9224671 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.54 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.25 | 16733453 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.51 | 20191521 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
manumycin |
4.36 | 19739265 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.99 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.31 | 15138306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.30 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.51 | 16337965 17638652 15173087 16785472 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.81 | 16938888 9664655 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.93 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.19 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.97 | 16145905 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.57 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
8.47 | 18337622 15102660 15162350 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.47 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.68 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.04 | 14991402 9664655 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.46 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.99 | 16778211 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.18 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.23 | 17551590 15992940 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
3.57 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.45 | 9562676 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.90 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.02 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.12 | 17596541 16294345 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.34 | 17217047 19075265 16935935 17361223 17506722 16788101 17301526 17294898 19225113 17107899 17649720 16823087 19029980 17712046 17368321 19642359 16891316 17339181 12679006 15748426 16140955 9834237 16766008 19035177 16331271 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.53 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.85 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
5.05 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
5.05 | 16603448 18383874 15113037 17045692 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.92 | 8603461 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.54 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.65 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.65 | 15246190 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.25 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
4.17 | 17352296 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.88 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.84 | 16940565 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.87 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.74 | 17488658 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.24 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.61 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.61 | 16946489 16594593 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.16 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.24 | 9142499 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.64 | 16436463 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.42 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.16 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.65 | 15113037 16929163 19003803 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.65 | 15976015 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.24 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.37 | 16644109 16289102 12479363 18247401 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.37 | 18626508 19082440 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.95 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.52 | 17410198 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.26 | 16723453 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.30 | 18722050 18286688 16160472 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
5.13 | 17352296 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.45 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.73 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.57 | 19015929 16424979 17172411 17522103 15786421 18396642 17498489 18567086 16951190 19084572 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.57 | 17261132 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.42 | 9562676 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.26 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
10.86 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.86 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.41 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
10.48 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
10.48 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.13 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.44 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.25 | 16287080 |